Millennium Management’s Forte Biosciences FBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $932K | Buy |
72,116
+57,511
| +394% | +$744K | ﹤0.01% | 3063 |
|
|
2025
Q1 | $113K | Buy |
+14,605
| New | +$113K | ﹤0.01% | 3736 |
|
|
2023
Q3 | – | Sell |
-2,284
| Closed | -$59.4K | – | 4286 |
|
|
2023
Q2 | $59.4K | Sell |
2,284
-1,665
| -42% | -$43.3K | ﹤0.01% | 3940 |
|
|
2023
Q1 | $100K | Buy |
3,949
+1,245
| +46% | +$31.5K | ﹤0.01% | 4060 |
|
|
2022
Q4 | $68K | Sell |
2,704
-2,540
| -48% | -$63.9K | ﹤0.01% | 4392 |
|
|
2022
Q3 | $140K | Buy |
5,244
+2,884
| +122% | +$77K | ﹤0.01% | 4589 |
|
|
2022
Q2 | $77K | Buy |
+2,360
| New | +$77K | ﹤0.01% | 4755 |
|
|
2022
Q1 | – | Sell |
-11,240
| Closed | -$601K | – | 5294 |
|
|
2021
Q4 | $601K | Sell |
11,240
-8,970
| -44% | -$480K | ﹤0.01% | 3873 |
|
|
2021
Q3 | $1.5M | Buy |
20,210
+19,447
| +2,549% | +$1.44M | ﹤0.01% | 3297 |
|
|
2021
Q2 | $641K | Sell |
763
-5,673
| -88% | -$4.77M | ﹤0.01% | 4019 |
|
|
2021
Q1 | $5.51M | Buy |
6,436
+4,875
| +312% | +$4.18M | ﹤0.01% | 1973 |
|
|
2020
Q4 | $1.42M | Buy |
+1,561
| New | +$1.42M | ﹤0.01% | 2706 |
|
|
2020
Q1 | – | Sell |
-257
| Closed | -$51K | – | 3303 |
|
|
2019
Q4 | $51K | Buy |
257
+163
| +173% | +$32.3K | ﹤0.01% | 3372 |
|
|
2019
Q3 | $23K | Sell |
94
-22
| -19% | -$5.38K | ﹤0.01% | 3431 |
|
|
2019
Q2 | $290K | Buy |
+116
| New | +$290K | ﹤0.01% | 3035 |
|
|
2019
Q1 | – | Sell |
-81
| Closed | -$248K | – | 3494 |
|
|
2018
Q4 | $248K | Sell |
81
-143
| -64% | -$438K | ﹤0.01% | 2925 |
|
|
2018
Q3 | $1.31M | Buy |
224
+170
| +315% | +$993K | ﹤0.01% | 2396 |
|
|
2018
Q2 | $188K | Sell |
54
-37
| -41% | -$129K | ﹤0.01% | 3197 |
|
|
2018
Q1 | $402K | Buy |
+91
| New | +$402K | ﹤0.01% | 2870 |
|